| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 16,210 | $30 | $421.5K |
| J3262 | Injection, tocilizumab, 1 mg | 60,190 | $10 | $301K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 75,200 | $1 | $300.8K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 26,250 | $10 | $210K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 12,150 | $10 | $133.7K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,930 | $30 | $133.4K |
| J0897 | Injection, denosumab, 1 mg | 5,820 | $20 | $104.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 360 | $100 | $35.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 480 | $70 | $31.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 310 | $90 | $26.6K |